Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Urheber
-
Fast, Loren
- Beteiligte Personen und Organisationen
-
Reagan, John
Quesenberry, Peter
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P7
- URN
-
urn:nbn:de:1111-2016072652087
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fast, Loren
- Reagan, John
- Quesenberry, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cellular immunotherapy for refractory hematological malignancies
Iron-laden blasts in refractory acute myeloid leukemia
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia
Recent developments in immunotherapy of acute myeloid leukemia
Natural killer cell-based immunotherapy for acute myeloid leukemia
Wilms' tumor 1 (WT1) specific immune cells as a tool for cellular immunotherapy in acute myeloid leukemia
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
New insights into antigen specific immunotherapy for chronic myeloid leukemia
Prognostic Implications of Cellular Senescence in Acute Myeloid Leukemia
Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience
Cellular immunotherapy for refractory hematological malignancies
Iron-laden blasts in refractory acute myeloid leukemia
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia
Recent developments in immunotherapy of acute myeloid leukemia
Natural killer cell-based immunotherapy for acute myeloid leukemia
Wilms' tumor 1 (WT1) specific immune cells as a tool for cellular immunotherapy in acute myeloid leukemia
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
New insights into antigen specific immunotherapy for chronic myeloid leukemia
Prognostic Implications of Cellular Senescence in Acute Myeloid Leukemia
Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience
Cellular immunotherapy for refractory hematological malignancies
Iron-laden blasts in refractory acute myeloid leukemia
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia
Recent developments in immunotherapy of acute myeloid leukemia
Natural killer cell-based immunotherapy for acute myeloid leukemia
Wilms' tumor 1 (WT1) specific immune cells as a tool for cellular immunotherapy in acute myeloid leukemia
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
New insights into antigen specific immunotherapy for chronic myeloid leukemia
Prognostic Implications of Cellular Senescence in Acute Myeloid Leukemia
Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia